Publications by authors named "F Matsuya"
Article Synopsis
- - A study examined medical records of 298 patients who had renal transplants, revealing that 15.1% developed malignant tumors, with skin cancer being the most common type.
- - The cumulative incidence of developing these tumors was 6.0% within 10 years and 17.9% within 20 years after the transplant.
- - Risk factors identified included older age at transplantation and the use of certain medications like cyclosporine and rituximab, with rituximab showing a potential link to increased tumor development.
Objective: To elucidate the effect of prior use of ethinylestradiol on enzalutamide treatment for men with castration-resistant prostate cancer.
Methods: We retrospectively analyzed data from 99 consecutive patients (median age 72 years, range 50-88 years) treated with enzalutamide for castration-resistant prostate cancer between May 2014 and November 2015 after receiving several lines of hormonal therapy.
Results: A total of 45 patients were given ethinylestradiol before enzalutamide.
A total of 100 patients with benign prostatic hyperplasia (BPH) and overactive bladder (OAB) symptoms (BPH/OAB), enrolled between June 2006 to March 2008, were randomly divided into 2 groups of morning medication (M) and evening medication (E) groups, then 50 mg of naftopidil was given once a day after breakfast or supper for 8 weeks. Data were available for efficacy analysis on 80 patients (M group ; 43, E group ; 37). Naftopidil significantly improved the overall international prostatic symptom score ; from 19.
View Article and Find Full Text PDFObjective: To present our experience of cavernous nerve graft reconstruction, using an autologous nerve vein-guide technique, to restore potency.
Patients And Methods: Prostate cancers frequently require radical resection involving one or both cavernous nerves that usually results in erectile dysfunction; nerve grafting has been used to restore erectile function, but clinical results are unsatisfactory owing to inadequate surgical techniques. In all, eight patients with prostate cancer who required radical resection involving one cavernous nerve had sural nerve grafting, with two or three sutures using the autologous vein-guide technique, in our unit between 2004 and 2005.